These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31846001)

  • 1. Vasodilator Therapy in Acute Heart Failure.
    Curfman G
    JAMA; 2019 Dec; 322(23):2288-2289. PubMed ID: 31846001
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilator treatment for acute and chronic heart failure.
    Chatterjee K; Parmley WW
    Br Heart J; 1977 Jul; 39(7):706-20. PubMed ID: 884021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Responses to vasodilator therapy in patients with congestive heart failure].
    Guo HY
    Sheng Li Ke Xue Jin Zhan; 1984 Jan; 15(1):30-4. PubMed ID: 6515395
    [No Abstract]   [Full Text] [Related]  

  • 4. [Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors].
    Kromer EP; Elsner D; Riegger GA
    Z Kardiol; 1991; 80 Suppl 2():11-5. PubMed ID: 2024538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of vasodilator agents in the treatment of heart failure.
    Lloyd EA
    S Afr Med J; 1979 Nov; 56(20):787-95. PubMed ID: 159502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration.
    Mets B; Michler RE; Delphin ED; Oz MC; Landry DW
    J Cardiothorac Vasc Anesth; 1998 Jun; 12(3):326-9. PubMed ID: 9636919
    [No Abstract]   [Full Text] [Related]  

  • 7. Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience.
    Pacher R; Stanek B
    Eur J Heart Fail; 1999 Aug; 1(3):263-8. PubMed ID: 10935673
    [No Abstract]   [Full Text] [Related]  

  • 8. Does hypoperfusion outperform blood pressure as a better predictor in the risk stratification of acute heart failure?
    Zhou Y; Liu F; Nie J
    Eur Heart J; 2020 Jul; 41(25):2411. PubMed ID: 32556154
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of vasodilator therapy in heart failure.
    Chatterjee K; Parmley WW
    Prog Cardiovasc Dis; 1977; 19(4):301-25. PubMed ID: 401541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of heart failure with vasodilator agents].
    Just H; Drexler H; Holubarsch C
    Z Kardiol; 1988; 77 Suppl 5():97-101. PubMed ID: 3066044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Present aspects of vasodilator therapy].
    Ito H; Gotoh K; Minatoguchi S; Asano K; Wada H; Takai K
    Jpn Circ J; 1993; 57 Suppl 4():1367-74. PubMed ID: 7966988
    [No Abstract]   [Full Text] [Related]  

  • 12. Preserved vasodilator effect of bradykinin in dogs with heart failure.
    Su JB; Barbe F; Houel R; Guyene TT; Crozatier B; Hittinger L
    Circulation; 1998 Dec 22-29; 98(25):2911-8. PubMed ID: 9860795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator therapy for heart failure. Concepts, applications, and challenges.
    Rubin SA; Swan HJ
    JAMA; 1981 Feb; 245(7):761-3. PubMed ID: 7463665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy.
    Peacock WF; Emerman CL; Young J
    J Card Fail; 2004 Apr; 10(2):120-5. PubMed ID: 15101023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vasodilation therapy].
    Widimský J
    Vnitr Lek; 1983 Mar; 29(3):274-82. PubMed ID: 6858011
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective renal vasodilation and active renal artery perfusion improve renal function in dogs with acute heart failure.
    Suehiro K; Shimizu J; Yi GH; Gu A; Wang J; Keren G; Burkhoff D
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1154-60. PubMed ID: 11504814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilators. A re-evaluation of their role in heart failure.
    Stevenson LW; Fonarow G
    Drugs; 1992 Jan; 43(1):15-36. PubMed ID: 1372857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure.
    Setoguchi S; Hirooka Y; Eshima K; Shimokawa H; Takeshita A
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):363-8. PubMed ID: 11862115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
    Ghio S; Crimi G; Temporelli PL; Traversi E; La Rovere MT; Cannito A; Vizza D; Scelsi L; Raineri C; Guazzi M; Oltrona Visconti L
    Eur J Heart Fail; 2018 Apr; 20(4):725-734. PubMed ID: 29148140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of venodilation during long-term vasodilator therapy of chronic left ventricular failure.
    Franciosa JA; Leddy CL; Schwartz DE
    Z Kardiol; 1983; 72 Suppl 3():168-72. PubMed ID: 6666217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.